Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
994,6 INR | -0,50% | +5,79% | +30,98% |
Vakgebied
Aantal werknemers: 14 593
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Formulations
79,4
%
| 43 673 | 82,3 % | 44 871 | 79,4 % | +2,74% |
Active Pharmaceutical Ingredients
20,6
%
| 9 385 | 17,7 % | 11 655 | 20,6 % | +24,19% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
100,0
%
| 53 058 | 100,0 % | 56 526 | 100,0 % | +6,54% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 76 | 01-05-83 | |
Director of Finance/CFO | 64 | 18-01-03 | |
Manisha Saraf
CMP | Compliance Officer | - | 01-04-23 |
Director/Board Member | 48 | 01-01-07 | |
Director/Board Member | 46 | 31-03-11 | |
Ajay Kumar Desai
PRN | Corporate Officer/Principal | - | 01-09-08 |
Mitanshu Shah
PRN | Corporate Officer/Principal | - | 01-05-06 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 76 | 01-05-83 | |
Director of Finance/CFO | 64 | 18-01-03 | |
Director/Board Member | 56 | 04-02-15 | |
Director/Board Member | 46 | 31-03-11 | |
Director/Board Member | 66 | 10-02-22 | |
Director/Board Member | 48 | 01-01-07 | |
Director/Board Member | 51 | 05-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 196 563 124 | 57 547 288 ( 29,28 %) | 0 | 29,28 % |
Bedrijfsgegevens
Alembic Pharmaceuticals Ltd.
Alembic Road
390003, Vadodara
+91 26 5663 7000
http://alembicpharmaceuticals.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,98% | 2,35 mld. | |
+33,25% | 699 mld. | |
+26,43% | 571 mld. | |
-3,55% | 364 mld. | |
+18,16% | 326 mld. | |
+4,36% | 286 mld. | |
+14,75% | 236 mld. | |
+4,93% | 198 mld. | |
-10,18% | 194 mld. | |
-3,69% | 149 mld. |
- Beurs
- Aandelen
- Koers APLLTD
- Onderneming Alembic Pharmaceuticals Limited